ERRATUM: Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2018
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836536/
https://www.ncbi.nlm.nih.gov/pubmed/29561929
http://dx.doi.org/10.6061/clinics/2018/e1err
_version_ 1783303981442793472
collection PubMed
description
format Online
Article
Text
id pubmed-5836536
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
record_format MEDLINE/PubMed
spelling pubmed-58365362018-03-05 ERRATUM: Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients Clinics (Sao Paulo) Erratum Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2018-02-22 2018 /pmc/articles/PMC5836536/ /pubmed/29561929 http://dx.doi.org/10.6061/clinics/2018/e1err Text en Copyright © 2018 CLINICS http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.
spellingShingle Erratum
ERRATUM: Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients
title ERRATUM: Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients
title_full ERRATUM: Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients
title_fullStr ERRATUM: Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients
title_full_unstemmed ERRATUM: Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients
title_short ERRATUM: Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients
title_sort erratum: systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836536/
https://www.ncbi.nlm.nih.gov/pubmed/29561929
http://dx.doi.org/10.6061/clinics/2018/e1err

Ejemplares similares